U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT06879366) titled 'Evaluation of the Efficacy of Aloe-Vera el Versus Bezydamine Hydrochloride in the Preventi... Read More
U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT06879457) titled 'mHealth Person-centred Self-care Support for Homebound Older Adults: A Hybrid Effectivenes... Read More
U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT06878625) titled 'A Multicenter, Prospective, Cohort Study of Trop-2 ADC Combination Therapy for Advanced Tr... Read More
U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT06879548) titled 'Bedside Assessment of Immune Function in Patients With Covid-19' on April 10, 2021. Brief... Read More
U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT06878430) titled 'Reducing Risk of Stroke and DementIa in PatientS with COVert CERebrovascular Disease' on M... Read More
U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT06879925) titled 'Physiological and QoL Benefits of Qi-Gong in Post-acute Sequelae of Covid-19' on Feb. 15. ... Read More
U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT06879535) titled 'Long-term Symptomatic Follow-up of Patients with Long COVID Syndrome' on March 12. Brief ... Read More
U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT06880601) titled 'Teclistamab Plus ALI for the Treatment of R/R Multiple Myeloma' on March 14. Brief Summar... Read More
U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT06880562) titled 'The RESPLASH Study' on March 11. Brief Summary: To assess the safety and effectiveness of... Read More
U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT06880029) titled 'Circadian Rhythm Impact on TNBC Response to Neoadjuvant Immunotherapy' on March 11. Brief... Read More